U S PHYSICAL THERAPY INC /NV
U S PHYSICAL THERAPY INC /NV
Subscribe to unlock 17+ years of financial data
Subscribe to unlock 17+ years of data
Financial Statements
Values in Millions ($) | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | 2024-06-30 | 2024-03-31 | 2023-12-31 | 2023-09-30 | 2023-06-30 | Subscriber-only column | Subscriber-only column | Subscriber-only column | Subscriber-only column | Data beyond 3 years is for subscribers only. Unlock 17+ years of financial data Start 7-day free trial |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Assets | |||||||||||||||||
Assets Current | |||||||||||||||||
Cash And Cash Equivalents At Carrying Value | 28 | 36 | 31 | 34 | 39 | 41 | 117 | 113 | 132 | 153 | 148 | 161 | |||||
Accounts Receivable Net Current | 69 | 64 | 68 | 66 | 65 | 59 | 57 | 55 | 55 | 52 | 53 | 54 | |||||
Accounts And Other Receivables Net Current | 28 | 24 | 24 | 27 | 26 | 27 | 20 | 22 | 22 | 18 | 18 | 17 | |||||
Other Assets Current | 14 | 16 | 16 | 13 | 15 | 11 | 11 | 12 | 12 | 11 | 9 | 10 | |||||
Assets Current | 139 | 140 | 138 | 141 | 145 | 138 | 205 | 202 | 221 | 233 | 228 | 242 | |||||
Property Plant And Equipm… | |||||||||||||||||
Furniture And Fixtures Gross | 70 | 68 | 68 | 67 | 69 | 68 | 67 | 66 | 66 | 64 | 65 | 63 | |||||
Leasehold Improvements Gross | 61 | 59 | 58 | 55 | 54 | 51 | 48 | 49 | 47 | 47 | 46 | 45 | |||||
Property Plant And Equipment Gross | 132 | 127 | 126 | 122 | 122 | 119 | 115 | 115 | 113 | 111 | 111 | 109 | |||||
Accumulated Depreciation Depletion And Amortizatio… | -93 | -91 | -91 | -90 | -90 | -87 | -89 | -88 | -87 | -85 | 85 | 84 | |||||
Property Plant And Equipment Net | 39 | 36 | 34 | 32 | 33 | 32 | 27 | 26 | 26 | 26 | 26 | 25 | |||||
Operating Lease Right Of Use Asset | 149 | 144 | 140 | 137 | 133 | 134 | 104 | 105 | 102 | 103 | 103 | 102 | |||||
Investments In Affiliates Subsidiaries Associates … | 12 | 12 | 12 | 12 | 12 | 12 | 12 | 12 | 12 | 12 | 12 | 12 | |||||
Goodwill | 716 | 692 | 690 | 678 | 674 | 667 | 555 | 549 | 534 | 510 | 523 | 507 | |||||
Intangible Assets Net Excluding Goodwill | 180 | 173 | 176 | 176 | 177 | 179 | 124 | 124 | 117 | 110 | 112 | 108 | |||||
Other Assets Noncurrent | 7 | 7 | 5 | 4 | 4 | 5 | 3 | 5 | 4 | 3 | 6 | 5 | |||||
Assets | 1,242 | 1,204 | 1,196 | 1,180 | 1,180 | 1,167 | 1,029 | 1,023 | 1,017 | 997 | 997 | 1,000 | |||||
Liabilities And Stockhold… | |||||||||||||||||
Liabilities Current | |||||||||||||||||
Accounts Payable Trade Current | 7 | 6 | 7 | 4 | 6 | 6 | 6 | 4 | 5 | 4 | 5 | 4 | |||||
Accrued Liabilities Current | 57 | 81 | 57 | 65 | 68 | 60 | 65 | 58 | 54 | 55 | 36 | 43 | |||||
Operating Lease Liability Current | 43 | 42 | 42 | 41 | 40 | 40 | 35 | 35 | 35 | 35 | 34 | 31 | |||||
Long Term Debt Current | 11 | 10 | 9 | 8 | 9 | 11 | 10 | 10 | 9 | 8 | 8 | 8 | |||||
Liabilities Current | 117 | 139 | 115 | 119 | 124 | 116 | 115 | 107 | 103 | 102 | 82 | 86 | |||||
Long Term Notes Payable | 1 | 0 | 1 | 0 | 0 | 1 | 1 | 2 | 1 | 1 | 2 | 2 | |||||
Long Term Line Of Credit | 75 | 31 | 27 | 25 | 28 | 11 | - | - | - | 0 | 0 | 0 | |||||
Long Term Loans Payable | 119 | 122 | 124 | 127 | 129 | 131 | 132 | 134 | 136 | 138 | 139 | 141 | |||||
Deferred Income Tax Liabilities Net | 31 | 28 | 36 | 34 | 34 | 29 | 25 | 27 | 27 | 25 | 26 | 23 | |||||
Operating Lease Liability Noncurrent | 115 | 111 | 106 | 104 | 101 | 102 | 77 | 78 | 76 | 77 | 77 | 79 | |||||
Other Liabilities Noncurrent | 2 | 3 | 5 | 5 | 5 | 18 | 8 | 6 | 3 | 2 | 15 | 13 | |||||
Liabilities | 459 | 434 | 414 | 414 | 421 | 408 | 358 | 353 | 345 | 345 | 342 | 344 | |||||
Redeemable Noncontrolling Interest Equity Carrying… | 313 | 293 | 278 | 263 | 260 | 269 | 187 | 184 | 191 | 175 | 175 | 166 | |||||
Stockholders Equity | |||||||||||||||||
Preferred Stock Value | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | |||||
Common Stock Value | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | |||||
Additional Paid In Capital | 288 | 286 | 297 | 295 | 293 | 290 | 287 | 285 | 284 | 281 | 279 | 277 | |||||
Accumulated Other Comprehensive Income Loss Net Of… | 1 | 1 | 1 | 1 | 2 | 3 | 1 | 4 | 4 | 3 | 6 | 5 | |||||
Retained Earnings Accumulated Deficit | 217 | 227 | 237 | 236 | 234 | 227 | 226 | 226 | 224 | 224 | 239 | 238 | |||||
Treasury Stock Value | -37 | -37 | -32 | -32 | -32 | -32 | -32 | -32 | -32 | -32 | -32 | -32 | |||||
Stockholders Equity | 469 | 476 | 505 | 502 | 497 | 489 | 484 | 485 | 481 | 477 | 492 | 488 | |||||
Minority Interest | 0 | 0 | 1 | 2 | 2 | 1 | 1 | 1 | 1 | 1 | 2 | 2 | |||||
Liabilities And Stockholders Equity | 1,242 | 1,204 | 1,196 | 1,180 | 1,180 | 1,167 | 1,029 | 1,023 | 1,017 | 997 | 1,010 | 1,000 | |||||
Allowance For Doubtful Accounts Receivable Current | 4 | 4 | 4 | 4 | 4 | 4 | 3 | 3 | 3 | 3 | 2 | 3 | |||||
Stockholders Equity Inclu… | |||||||||||||||||
Preferred Stock Par Or Stated Value Per Share | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | |||||
Preferred Stock Shares Authorized | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | |||||
Preferred Stock Shares Issued | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | |||||
Preferred Stock Shares Outstanding | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | |||||
Common Stock Par Or Stated Value Per Share | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | |||||
Common Stock Shares Authorized | 20 | 20 | 20 | 20 | 20 | 20 | 20 | 20 | 20 | 20 | 20 | 20 | |||||
Common Stock Shares Issued | 18 | 17 | 17 | 17 | 17 | 17 | 17 | 17 | 17 | 17 | 17 | 17 | |||||
Treasury Stock Common Shares | 2 | 2 | 2 | 2 | 2 | 2 | 2 | 2 | 2 | 2 | 2 | 2 | |||||
Subscribe to unlock 17+ years of financial data, unlimited metrics, and saved tables
Subscribe to unlock 17+ years of data, unlimited metrics, and saved tables
Custom Table
Subscribe to unlock 17+ years of financial data, unlimited metrics, transformations, and saved visuals
Subscribe to unlock 17+ years of data, unlimited metrics, transformations, and saved visuals
Interactive Financial Visualizations
Subscribe to unlock 17+ years of financial data
Subscribe to unlock 17+ years of data
Earnings Market Reaction
| Fiscal Year | Q1 1 Month | Q1 2 Month | Q1 3 Month | Q2 1 Month | Q2 2 Month | Q2 3 Month | Q3 1 Month | Q3 2 Month | Q3 3 Month | Q4 1 Month | Q4 2 Month | Q4 3 Month |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026 | 9.18% | 16.86% | 26.72% | - | - | - | - | - | - | - | - | - |
| 2025 | 1.85% | 7.34% | 0.84% | -4.96% | -4.37% | 6.82% | 0.60% | 10.34% | 16.75% | -10.44% | -7.15% | -23.84% |
| 2024 | -0.89% | -10.70% | -4.99% | 4.13% | -0.19% | 0.22% | 4.38% | -3.95% | -5.63% | -9.15% | -10.92% | -6.11% |
| 2023 | - | - | - | -7.64% | -15.48% | -22.15% | 6.54% | 13.10% | 14.33% | 4.57% | -6.36% | 0.85% |
Data beyond 3 years is for subscribers only. Unlock 17+ years of financial data Start 7-day free trial | ||||||||||||
Subscribe to unlock 17+ years of financial data and 90+ calculated metrics
Subscribe to unlock 17+ years of data and 90+ calculated metrics
Performance and Valuation Metrics
Metrics | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | 2024-06-30 | 2024-03-31 | 2023-12-31 | 2023-09-30 | 2023-06-30 | Subscriber-only column | Subscriber-only column | Subscriber-only column | Subscriber-only column | Data beyond 3 years is for subscribers only. Unlock 17+ years of financial data Start 7-day free trial |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Liquidity Ratios | |||||||||||||||||
| Current Ratio | 1.19 | 1.01 | 1.20 | 1.18 | 1.17 | 1.18 | 1.78 | 1.88 | 2.16 | 2.28 | 2.77 | 2.82 | |||||
| Quick Ratio | 1.19 | 1.01 | 1.20 | 1.18 | 1.17 | 1.18 | 1.78 | 1.88 | 2.16 | 2.28 | 2.77 | 2.82 | |||||
| Working Capital | 21.81M | 950.00K | 23.36M | 21.69M | 21.56M | 21.30M | 89.57M | 94.58M | 118.61M | 131.19M | 146.14M | 155.98M | |||||
Leverage & Debt | |||||||||||||||||
| Debt to Equity | 0.98 | 0.91 | 0.82 | 0.82 | 0.85 | 0.83 | 0.74 | 0.73 | 0.72 | 0.72 | 0.70 | 0.70 | |||||
| Debt Ratio | 0.37 | 0.36 | 0.35 | 0.35 | 0.36 | 0.35 | 0.35 | 0.35 | 0.34 | 0.35 | 0.34 | 0.34 | |||||
Efficiency & Turnover | |||||||||||||||||
| Asset Turnover TTM | 0.66 | 0.66 | 0.68 | 0.66 | 0.64 | 0.62 | 0.64 | 0.62 | 0.65 | 0.65 | 0.66 | 0.65 | |||||
| Days Sales Outstanding TTM | 30.71 | 28.81 | 29.98 | 30.17 | 31.34 | 30.15 | 31.08 | 31.68 | 33.40 | 31.32 | 31.71 | 32.94 | |||||
| Receivables Turnover TTM | 11.89 | 12.67 | 12.17 | 12.10 | 11.65 | 12.11 | 11.74 | 11.52 | 10.93 | 11.65 | 11.51 | 11.08 | |||||
Per Share Metrics | |||||||||||||||||
| Diluted EPS TTM | 2.49 | 2.61 | 3.87 | 3.44 | 3.14 | 3.03 | 1.84 | 2.02 | 2.25 | 2.62 | 1.80 | 1.99 | |||||
| Free Cash Flow Per Share TTM | 4.40 | 4.02 | 3.74 | 4.01 | 3.70 | 4.36 | 4.87 | 4.49 | 4.39 | 5.12 | 4.30 | 4.49 | |||||
| Dividend Per Share TTM | 2.09 | 2.04 | 2.03 | 2.01 | 2.00 | 1.97 | 1.96 | 1.94 | 1.82 | 1.93 | 1.76 | 1.84 | |||||
Margin Metrics | |||||||||||||||||
| Gross Profit Margin TTM | 19.03% | 19.17% | 18.73% | 18.41% | 18.10% | 18.46% | 18.88% | 19.23% | 19.45% | 20.09% | 20.10% | 20.26% | |||||
| Operating Profit Margin TTM | 10.00% | 11.10% | 11.80% | 10.56% | 9.68% | 9.38% | 6.58% | 7.25% | 8.17% | 8.61% | 10.10% | 10.12% | |||||
| Net Profit Margin TTM | 4.76% | 5.07% | 7.76% | 7.17% | 6.78% | 6.79% | 4.31% | 4.85% | 5.53% | 6.15% | 4.56% | 4.69% | |||||
Growth Metrics | |||||||||||||||||
| Net Revenue Growth (1Y) | 13.73% | 16.33% | 17.50% | 16.24% | 14.30% | 11.00% | 9.22% | 8.07% | 7.37% | 9.34% | 9.12% | 9.98% | |||||
| Net Income Growth (1Y) | -20.26% | -13.20% | 111.69% | 72.02% | 40.23% | 22.51% | 3.10% | 11.59% | 7.08% | 15.74% | -35.76% | -35.73% | |||||
| EPS Growth (1Y) | -20.44% | -13.83% | 109.92% | 70.61% | 39.17% | 15.39% | 2.49% | 1.58% | -7.13% | 5.93% | -44.27% | -39.11% | |||||
Valuation Metrics | |||||||||||||||||
| P/E TTM | 29.83 | 29.54 | 21.52 | 22.15 | 22.37 | 28.25 | 44.03 | 43.68 | 47.59 | 33.59 | 48.00 | 57.26 | |||||
| P/B TTM | 2.40 | 2.45 | 2.51 | 2.31 | 2.13 | 2.63 | 2.53 | 2.74 | 3.35 | 2.62 | 2.63 | 3.20 | |||||
| P/S TTM | 1.42 | 1.50 | 1.67 | 1.59 | 1.52 | 1.92 | 1.90 | 2.12 | 2.63 | 2.07 | 2.19 | 2.69 | |||||
| Market Cap | 1.13B | 1.17B | 1.27B | 1.16B | 1.06B | 1.29B | 1.22B | 1.33B | 1.61B | 1.25B | 1.29B | 1.56B | |||||
| Enterprise Value | 1.11B | 1.14B | 1.24B | 1.13B | 1.03B | 1.26B | 1.12B | 1.23B | 1.49B | 1.11B | 1.16B | 1.41B | |||||
Calculated Values | |||||||||||||||||
| Free Cash Flow TTM | 66.68M | 60.99M | 56.90M | 60.87M | 55.92M | 65.75M | 73.45M | 67.67M | 65.98M | 72.68M | 64.41M | 61.60M | |||||
| Net Debt | -17.07M | -25.29M | -21.72M | -25.60M | -29.54M | -29.46M | -106.82M | -101.70M | -122.26M | -143.85M | -138.09M | -151.01M | |||||
Per-Share and Margin | |||||||||||||||||
| EPS TTM | |||||||||||||||||
| Adjusted EPS TTM | |||||||||||||||||
| Cash Flow Per Share TTM | |||||||||||||||||
| Pretax Margin TTM | |||||||||||||||||
| Stock Comp to Revenue TTM | |||||||||||||||||
Turnover Ratios and Averages | |||||||||||||||||
| Average Assets | |||||||||||||||||
| Average Equity | |||||||||||||||||
| Average Inventory | |||||||||||||||||
| Average Receivables | |||||||||||||||||
| Average Accounts Payables | |||||||||||||||||
| Inventory Turnover TTM | |||||||||||||||||
| Payables Turnover TTM | |||||||||||||||||
| Days Inventory Outstanding TTM | |||||||||||||||||
| Days Payables Outstanding TTM | |||||||||||||||||
| Cash Conversion Cycle TTM | |||||||||||||||||
| Working Capital to Revenue | |||||||||||||||||
| Deferred Revenue to Revenue | |||||||||||||||||
Growth Rates | |||||||||||||||||
| Total Assets Growth (1Y) | |||||||||||||||||
| Total Assets Growth (3Y) | |||||||||||||||||
| Total Assets Growth (5Y) | |||||||||||||||||
| Dividends Paid Growth (1Y) | |||||||||||||||||
| Dividends Paid Growth (3Y) | |||||||||||||||||
| Dividends Paid Growth (5Y) | |||||||||||||||||
| EPS Growth (3Y) | |||||||||||||||||
| EPS Growth (5Y) | |||||||||||||||||
| Net Income Growth (3Y) | |||||||||||||||||
| Net Income Growth (5Y) | |||||||||||||||||
| Net Profit Margin Growth (1Y) | |||||||||||||||||
| Net Profit Margin Growth (3Y) | |||||||||||||||||
| Net Profit Margin Growth (5Y) | |||||||||||||||||
| Net Revenue Growth (3Y) | |||||||||||||||||
| Net Revenue Growth (5Y) | |||||||||||||||||
| Deferred Revenue Growth (1Y) | |||||||||||||||||
| Retained Earnings Growth (1Y) | |||||||||||||||||
Credit, Liquidity, Returns, Payout | |||||||||||||||||
| Cash Ratio | |||||||||||||||||
| Net Working Capital | |||||||||||||||||
| Debt to EBITDA TTM | |||||||||||||||||
| Net Debt to EBITDA TTM | |||||||||||||||||
| Net Debt to Equity | |||||||||||||||||
| Altman A | |||||||||||||||||
| Altman B | |||||||||||||||||
| Altman C | |||||||||||||||||
| Altman D | |||||||||||||||||
| Altman E | |||||||||||||||||
| Altman Z-Score | |||||||||||||||||
| ROA TTM | |||||||||||||||||
| ROE TTM | |||||||||||||||||
| NOPAT TTM | |||||||||||||||||
| ROIC TTM | |||||||||||||||||
| Effective Tax Rate TTM | |||||||||||||||||
| Payout Ratio TTM | |||||||||||||||||
| Dilution Ratio | |||||||||||||||||
| Retained Earnings to Equity | |||||||||||||||||
| Treasury Stock to Equity | |||||||||||||||||
| Treasury Stock Change (1Y) | |||||||||||||||||
| Accrued to Current Liabilities | |||||||||||||||||
Valuation Ratios | |||||||||||||||||
| P/CF TTM | |||||||||||||||||
| Dividend Yield TTM | |||||||||||||||||
| Free Cash Flow Yield TTM | |||||||||||||||||
| EV EBITDA TTM | |||||||||||||||||
| EV EBIT TTM | |||||||||||||||||
| Stock Compensation TTM | |||||||||||||||||
| Adjusted Net Income TTM | |||||||||||||||||
| Billings TTM | |||||||||||||||||
| Total Debt | |||||||||||||||||
| Invested Capital | |||||||||||||||||
Subscribe to unlock 17+ years of financial data
Subscribe to unlock 17+ years of data
Insider Transactions
Subscribe to unlock 17+ years of financial data
Subscribe to unlock 17+ years of data
Institutional Ownership
U S PHYSICAL THERAPY INC /NV (USPH) — SEC Financial Statements & Analysis
U S PHYSICAL THERAPY INC /NV (USPH) is a services-health services company, incorporated in NV. U S PHYSICAL THERAPY INC /NV trades on NYSE as: USPH. Based on its latest SEC filing (Form 10-Q, period ending 2026-03-31), U S PHYSICAL THERAPY INC /NV reported a 13.73% year-over-year revenue growth, a Gross Profit Margin of 19.03% (TTM), a Debt-to-Equity ratio of 0.98x, a Price-to-Sales (P/S) ratio of 1.42x (TTM), a Price-to-Book (P/B) ratio of 2.4 (TTM), at a market cap of $1.13B. Figures below are sourced from SEC EDGAR, as-filed.
- Net Revenue TTM Growth 1Y
- 13.73%
- Gross Profit Margin TTM
- 19.03%
- Debt To Equity
- 0.98x
- P/S TTM
- 1.42x
- P/B TTM
- 2.4
- Market Cap
- $1.13B
Data as of 2026-03-31 · Source: SEC EDGAR
Frequently Asked Questions
What industry is U S PHYSICAL THERAPY INC /NV in?
U S PHYSICAL THERAPY INC /NV (USPH) operates in the Services-Health Services industry.
What is USPH's market cap?
U S PHYSICAL THERAPY INC /NV (USPH) has a market capitalization of $1.13B as of 2026-03-31.
What is USPH's P/E ratio?
U S PHYSICAL THERAPY INC /NV (USPH)'s trailing twelve month P/E ratio is 29.83x as of 2026-03-31.
What exchange does USPH trade on?
U S PHYSICAL THERAPY INC /NV (USPH) trades on the NYSE.
Where is U S PHYSICAL THERAPY INC /NV incorporated?
U S PHYSICAL THERAPY INC /NV is incorporated in NV.